US House Passes Bill to Blacklist Some China Biotech Firms
- Chinese companies find themselves under bipartisan scrutiny
- Lawmaker, lobbyists failed in last-ditch battle against bill
This article is for subscribers only.
Supply Lines is a daily newsletter that tracks global trade. Sign up here.
China hawks in the US House overcame a last-ditch lobbying effort and passed legislation Monday night that would blacklist Chinese biotech companies and their US subsidiaries.